Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.5.0.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2016
Dec. 31, 2015
Current assets    
Cash and cash equivalents $ 140,440 $ 194,263
Short-term deposits 47,064 54,620
Accounts receivable, net of allowance for doubtful accounts of $- and $- (including amounts due from related parties of $- and $2)   744
Other current assets and prepaid expenses (including current portion of clinical materials) 12,040 13,420
Total current assets 199,544 263,047
Restricted cash 4,146 4,508
Clinical materials 2,741 4,736
Property, plant and equipment, net 15,086 13,225
Intangibles, net 1,127 305
Total assets 222,644 285,821
Current liabilities    
Accounts payable (including amounts due to related parties of $125 and $-) 3,193 7,884
Accrued expenses and other accrued liabilities (including amounts due to related parties of $27 and $288) 9,954 7,518
Deferred revenue 9,514 12,487
Total current liabilities 22,661 27,889
Deferred revenue, less current portion 19,335 22,939
Other liabilities 644  
Total liabilities 42,640 50,828
Contingencies and commitments - Note 8
Stockholders' Equity    
Common stock - Ordinary shares par value GBP 0.001, 574,711,900 authorized and 424,711,900 issued and outstanding (2015: 574,711,900 authorized and 424,711,900 issued and outstanding) 682 682
Additional paid in capital 339,188 332,363
Accumulated other comprehensive loss (13,788) (8,139)
Accumulated deficit (146,078) (89,913)
Total stockholders' equity 180,004 234,993
Total liabilities and stockholders' equity $ 222,644 $ 285,821